IV Fluid Supply Updates

On the cutting edge

Our innovative researchers make groundbreaking advances in the fight against cancer that help save lives around the world.

Research Programs
a woman wearing a mask uses a syringe in a research lab

Research

National Cancer Institute Designated Cancer Center logo

Today's research leads to tomorrow's cures.

MUSC Hollings Cancer Center is committed to translational science that accelerates lifesaving discoveries getting from the lab to the bedside to benefit our patients, both at Hollings and beyond. Hollings is home to more than 140 scientists conducting research and collaborating on better ways to prevent, detect, diagnose, and treat this complex disease. As one of 72 National Cancer Institute-designated cancer centers, Hollings continues to attract top cancer researchers from leading institutions across the country who conduct research in the community, laboratory, and clinic. The center has an annual research funding portfolio of over $50 million and offers more than 200 clinical trials.


“ This is lifesaving research we're doing to discover and invent new treatments, to test them, and to make sure the outcomes of our patients are improved by putting these new treatments in place. ”

Dr. Raymond DuBois, director of MUSC Hollings Cancer Center

Dr. Raymond DuBois wearing a white physician's coat

Clinical Trial Development

Are you a researcher or doctor with an idea for a clinical trial? The Hollings Advisory for Rapid Translation (HART) provides expertise and mentorship to help you develop your trial.

Learn about HART

Latest Research News

peering through shelving at a scientist in white coat and blue gloves concentrating on work in the lab

Catalyst Award

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Dr. Joe Delaney in his MUSC Hollings lab

Tackling Cancer Resistance

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.
cartoon illustration of a man laying down to enter a CT machine for a lung scan

Lung Cancer Screening

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

a word cloud in the shape of an apple with Quit Smoking being the most prominent and other words including life, muscle and more

Quitting Smoking after Cancer

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

a scientist in a white lab coat sits at the bench next to a microscope with a computer screen showing the image

Identifying Targets

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

two women in business casual attire pose in a garden setting

Cannabis and Cancer

Cancer patients who smoke cigarettes are more likely than nonsmokers to use cannabis, researchers find.

a researcher in a white coat in a lab setting

Harnessing AI

An artificial intelligence initiative underway at Hollings seeks to provide oncologists with insights into customized treatment options for individual patients.
a man and woman in white lab coats in a lab setting talking and working

Modeling Ovarian Cancer

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Wyatt Wofford (left) and Dr. Besim Ogretmen (right)

Immunotherapy in Breast Cancer

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.
More Research News

Education & Training

group photo of 2019 South Carolina Cancer Health Equity Consortium student fellows

Hollings is committed to developing the researchers who will go on to make cancer research breakthroughs in the years ahead. Starting with high school students, Hollings offers education, training, mentoring, and career development opportunities across all levels.

Learn about our programs

Funding Opportunities

researcher works with equipment in the lab

Hollings offers intramural support opportunities for students, postdoctoral trainees, and faculty conducting cancer-related research and clinical services.

Learn about funding

Hollings Membership

Hollings seeks MUSC faculty who have an interest in cancer research and provides opportunities for interactions and collaboration among investigators with common interests. Members are given priority access to Hollings-supported shared resources and are eligible to apply for pilot project funding.

Become a member